Cargando…
Are Faecal Microbiota Analyses on Species-Level Suitable Clinical Biomarkers? A Pilot Study in Subjects with Morbid Obesity
Background: An abnormal faecal microbiota could be a causal factor for disease. This study evaluated a new method for faecal microbiota analysis in subjects with obesity and irritable bowel syndrome. Methods: The study had a matched case-control design. Forty-six subjects with morbid obesity (define...
Autores principales: | Farup, Per G., Maseng, Maria G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005088/ https://www.ncbi.nlm.nih.gov/pubmed/33806783 http://dx.doi.org/10.3390/microorganisms9030664 |
Ejemplares similares
-
Are Nonnutritive Sweeteners Obesogenic? Associations between Diet, Faecal Microbiota, and Short-Chain Fatty Acids in Morbidly Obese Subjects
por: Farup, Per G., et al.
Publicado: (2019) -
Faecal Microbial Markers and Psychobiological Disorders in Subjects with Morbid Obesity. A Cross-Sectional Study
por: Farup, Per G, et al.
Publicado: (2018) -
Changes in Faecal Short-Chain Fatty Acids after Weight-Loss Interventions in Subjects with Morbid Obesity
por: Farup, Per G, et al.
Publicado: (2020) -
APOE – a genetic marker of comorbidity in subjects with morbid obesity
por: Farup, Per G., et al.
Publicado: (2020) -
APOE Polymorphism and Endocrine Functions in Subjects with Morbid Obesity Undergoing Bariatric Surgery
por: Farup, Per G., et al.
Publicado: (2022)